Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2020

26.05.2020 | Retinal Disorders

Optical coherence tomography characteristics of taxane-induced macular edema and other multimodal imaging findings

verfasst von: Joel M. Perez, Kelvin Teo, Ricardo Ong, Maiko Maruyama-Inoue, K. Bailey Freund, Anna C. S. Tan

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify common optical coherence tomography (OCT) characteristics of taxane-related CME (T-CME) to differentiate it from CME associated with other causes (O-CME) and to present multimodal imaging findings of T-CME.

Methods

To differentiate T-CME from O-CME, pooled SD-OCT images from 14 previous publications and images obtained from our multicenter case series of 3 patients with multimodal imaging of T-CME were compared with 16 consecutive cases of O-CME. Images were graded by 2 masked retinal specialists based on the presence of pre-specified OCT characteristics such as CME centered around fovea, outer retinal cysts more prominent compared with inner retinal cysts, continuous outer plexiform layer (OPL) and inner plexiform layer (IPL), intact outer retina layer, attenuation of outer retina layers by overlying retinal layers, and the presence of subretinal fluid.

Results

Comparing 19 and 16 SD-OCT images of T-CME and O-CME, respectively, T-CME showed a significantly higher rate of the continuous OPL and IPL layer and a higher composite score of the various pre-specified OCT features. All other individual features showed no significant difference between T-CME and O-CME. All our patients had T-CME that had vague petalloid patterns on the late-stage FFA, with late leakage on ICGA. OCT angiography in one case showed an intact foveal avascular zone.

Conclusions

T-CME is a rare but important complication of taxane chemotherapy. Specific OCT features such as an intact continuous OPL and IPL layer combined with other OCT features can help distinguish T-CME from O-CME, and early diagnosis is clinically important as cessation of taxanes before the retinal layers are disrupted may prevent permanent vision loss.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yokoe T, Fukada I, Kobayashi K et al (2017) Cystoid macular edema during treatment with paclitaxel and bevacizumab in a patient with metastatic breast cancer: a case report and literature review. Case Rep Oncol 10(2):605–612PubMedPubMedCentralCrossRef Yokoe T, Fukada I, Kobayashi K et al (2017) Cystoid macular edema during treatment with paclitaxel and bevacizumab in a patient with metastatic breast cancer: a case report and literature review. Case Rep Oncol 10(2):605–612PubMedPubMedCentralCrossRef
2.
3.
Zurück zum Zitat Hofstra L, de Vries E, Willemse P (1997) Ophthalmic toxicity following paclitaxel infusion. Ann Oncol 8(10):1053–1053PubMedCrossRef Hofstra L, de Vries E, Willemse P (1997) Ophthalmic toxicity following paclitaxel infusion. Ann Oncol 8(10):1053–1053PubMedCrossRef
4.
5.
Zurück zum Zitat Teitelbaum B, Tresley D (2003) Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci 80(4):277–279PubMedCrossRef Teitelbaum B, Tresley D (2003) Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci 80(4):277–279PubMedCrossRef
9.
10.
Zurück zum Zitat Murphy C, Walsh J, Hudis C, Lake D, Theodoulou M (2010) Cystoid macular edema secondary to nab-paclitaxel therapy. J Clin Oncol 28(33):e684–e687PubMedCrossRef Murphy C, Walsh J, Hudis C, Lake D, Theodoulou M (2010) Cystoid macular edema secondary to nab-paclitaxel therapy. J Clin Oncol 28(33):e684–e687PubMedCrossRef
11.
Zurück zum Zitat Kuznetcova TI, Cech P, Herbort CP (2012) The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol 32(3):299–304PubMedCrossRef Kuznetcova TI, Cech P, Herbort CP (2012) The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol 32(3):299–304PubMedCrossRef
12.
Zurück zum Zitat Matsuoka N, Hasebe H, Mayama T, Fukuchi T (2015) Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound paclitaxel (abraxane). Case Rep Ophthalmol Med 2015:1–4 Matsuoka N, Hasebe H, Mayama T, Fukuchi T (2015) Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound paclitaxel (abraxane). Case Rep Ophthalmol Med 2015:1–4
13.
Zurück zum Zitat Freitas-da-Costa P, Brandão E, Bragança T, Falcão-Reis F, Carneiro A (2015) Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction. Cutan Ocul Toxicol 34(4):347–349PubMedCrossRef Freitas-da-Costa P, Brandão E, Bragança T, Falcão-Reis F, Carneiro A (2015) Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction. Cutan Ocul Toxicol 34(4):347–349PubMedCrossRef
16.
Zurück zum Zitat Telander DG, Sarraf D (2007) Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol 22(3):151–153PubMedCrossRef Telander DG, Sarraf D (2007) Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol 22(3):151–153PubMedCrossRef
17.
Zurück zum Zitat Semb K, Aamdal S, Oian P (1998) Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16(10):3426–3432PubMedCrossRef Semb K, Aamdal S, Oian P (1998) Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16(10):3426–3432PubMedCrossRef
18.
Zurück zum Zitat Spirn M, Warren F, Guyer D, Klancnik J, Spaide R (2003) Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 135(6):913–914PubMedCrossRef Spirn M, Warren F, Guyer D, Klancnik J, Spaide R (2003) Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 135(6):913–914PubMedCrossRef
19.
Zurück zum Zitat Coscas G, Loewenstein A, Cunha-Vaz J, Soubrane G (2017) Macular edema, 2nd edn. S. Karger Ag, Basel, pp 1–10CrossRef Coscas G, Loewenstein A, Cunha-Vaz J, Soubrane G (2017) Macular edema, 2nd edn. S. Karger Ag, Basel, pp 1–10CrossRef
20.
Zurück zum Zitat Makri OE, Georgalas I, Georgakopoulos CD (2013) Drug-induced macular edema. Drugs. 73(8):789–802PubMedCrossRef Makri OE, Georgalas I, Georgakopoulos CD (2013) Drug-induced macular edema. Drugs. 73(8):789–802PubMedCrossRef
21.
Zurück zum Zitat Bassi E, Loizzi V, Furino C et al (2017) Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: a case report. Mol Clin Oncol 7(2):285–287PubMedPubMedCentralCrossRef Bassi E, Loizzi V, Furino C et al (2017) Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: a case report. Mol Clin Oncol 7(2):285–287PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Nomi N, Ota M, Fukumura M et al (2017) Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy. Jpn J Ophthalmol 62(2):163–167PubMedCrossRef Nomi N, Ota M, Fukumura M et al (2017) Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy. Jpn J Ophthalmol 62(2):163–167PubMedCrossRef
23.
Zurück zum Zitat Chelala E, Arej N, Antoun J et al (2017) Central macular thickness monitoring after a taxane-based therapy in visually asymptomatic patients. Chemotherapy. 62(3):199–204PubMedCrossRef Chelala E, Arej N, Antoun J et al (2017) Central macular thickness monitoring after a taxane-based therapy in visually asymptomatic patients. Chemotherapy. 62(3):199–204PubMedCrossRef
24.
Zurück zum Zitat Crabtree DV, Ojima I, Geng X, Adler AJ (2001) Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem 9(8):1967–1976PubMedCrossRef Crabtree DV, Ojima I, Geng X, Adler AJ (2001) Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem 9(8):1967–1976PubMedCrossRef
25.
Zurück zum Zitat Meyer K, Klink T, Ugurel S, Bröcker E (2011) Regression of paclitaxel-induced maculopathy with oral acetazolamide. Graefes Arch Clin Exp Ophthalmol 250(3):463–464PubMedCrossRef Meyer K, Klink T, Ugurel S, Bröcker E (2011) Regression of paclitaxel-induced maculopathy with oral acetazolamide. Graefes Arch Clin Exp Ophthalmol 250(3):463–464PubMedCrossRef
Metadaten
Titel
Optical coherence tomography characteristics of taxane-induced macular edema and other multimodal imaging findings
verfasst von
Joel M. Perez
Kelvin Teo
Ricardo Ong
Maiko Maruyama-Inoue
K. Bailey Freund
Anna C. S. Tan
Publikationsdatum
26.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2020
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-020-04755-z

Weitere Artikel der Ausgabe 8/2020

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.